Acadia Healthcare Co Q4 2023 Adj EPS $0.85 Beats $0.79 Estimate, Sales $742.80M Beat $727.60M Estimate
Portfolio Pulse from Benzinga Newsdesk
Acadia Healthcare Co (ACHC) reported Q4 2023 adjusted EPS of $0.85, surpassing the $0.79 estimate, with sales of $742.80M exceeding the $727.60M estimate, marking a 10% increase from the previous year.
February 27, 2024 | 9:11 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Acadia Healthcare Co reported a Q4 2023 adjusted EPS of $0.85, beating estimates, and sales of $742.80M, also above expectations, indicating a 10% year-over-year growth.
The positive earnings and sales beat, coupled with a significant year-over-year growth, suggest a strong performance by Acadia Healthcare Co. This is likely to instill investor confidence and could lead to a short-term uptick in ACHC's stock price.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100